Home / Germany / STRATEC Biomedical AG
STRATEC Biomedical AG
Short position disclosed on May 22, 2017.
0.50% of the capital sold short
1 disclosing fund
18 disclosures on record
DE0007289001 ISIN code
Evolution of the disclosed total
0%0.2%0.4%0.6%
Oct 2025Jan 2026Apr 2026Jul 2026
March 5, 2013 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| BlackRock Investment Management (UK) Limited | 0.50% | unchanged | May 22, 2017 |
Get the moves on STRATEC Biomedical AG by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
Download 18 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Germany
- TUI AG 8.56% of the capital sold short
- HelloFresh SE 7.84% of the capital sold short
- AUTO1 Group SE 7.23% of the capital sold short
- Hugo Boss AG 7.19% of the capital sold short
- Zalando SE 6.11% of the capital sold short
- Gerresheimer AG 5.99% of the capital sold short
- PVA TePla AG 5.72% of the capital sold short
- Velo3D Inc 5.72% of the capital sold short
- Cancom SE 5.55% of the capital sold short
- Puma SE 5.41% of the capital sold short
- RENK Group AG 5.31% of the capital sold short
- TAG Immobilien AG 5.19% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, STRATEC Biomedical AG, source Bundesanzeiger, data as at May 22, 2017, https://www.quivad.com/action/stratec-biomedical-ag